| Literature DB >> 31959786 |
Pedro J García-Moreno1,2, Simon Gregersen3, Elham R Nedamani4, Tobias H Olsen5, Paolo Marcatili5, Michael T Overgaard3, Mogens L Andersen6, Egon B Hansen4, Charlotte Jacobsen4.
Abstract
In this work, we developed a novel approach combining bioinformatics, testing of functionality and bottom-up proteomics to obtain peptide emulsifiers from potato side-streams. This is a significant advancement in the process to obtain emulsifier peptides and it is applicable to any type of protein. Our results indicated that structure at the interface is the major determining factor of the emulsifying activity of peptide emulsifiers. Fish oil-in-water emulsions with high physical stability were stabilized with peptides to be predicted to have facial amphiphilicity: (i) peptides with predominantly α-helix conformation at the interface and having 18-29 amino acids, and (ii) peptides with predominantly β-strand conformation at the interface and having 13-15 amino acids. In addition, high physically stable emulsions were obtained with peptides that were predicted to have axial hydrophobic/hydrophilic regions. Peptides containing the sequence FCLKVGV showed high in vitro antioxidant activity and led to emulsions with high oxidative stability. Peptide-level proteomics data and sequence analysis revealed the feasibility to obtain the potent emulsifier peptides found in this study (e.g. γ-1) by trypsin-based hydrolysis of different side streams in the potato industry.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31959786 PMCID: PMC6971092 DOI: 10.1038/s41598-019-57229-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Emulsifiers peptides with facial amphiphilicity: (a) α–helix, and (b) β–strand; or (c) with defined hydrophilic and hydrophobic regions (e.g. a half) in their sequence (γ-peptides: (i) unordered, (ii) β-strand and (iii) α-helix). Figure 1 was created with PyMOL, Version 1.8.4.0. (https://sourceforge.net/projects/pymol/files/pymol/1.8/).
Properties of potato peptides predicted by bioinformatics to have emulsifying activity.
| Peptide | Sequence | Score* | AA Separation** | Accession | Number of | α-helical content, %*** | β-strand content, %*** | Purity****, % | Mw, g/mol | pI***** | Net charge***** |
|---|---|---|---|---|---|---|---|---|---|---|---|
| α-10 | KKPVSKDSPETYEEALKRFAKLLSDRKKL | 2.176 | — | P15477 P11768 Q42502 Q3YJT3 | 29 | 26 | 7 | 92.7 | 3405.9 | 10.38 | 4 |
| α-11 | EALKRFAKLLSD | 3.522 | — | P15478 P15477 Q3YJT5 P11768 Q2MY60 Q2MY43 Q42502 Q3YJT3 | 12 | — | — | 97.0 | 1390.6 | 9.92 | 1 |
| α-12 | DSPETYEEALKRFAKLLSD | 3.037 | — | P15477 P11768 Q42502 Q3YJT3 | 19 | 74 | 5 | 94.9 | 2212.4 | 4.16 | −2 |
| α-13 | NRPFAAAKDIVPFYFEHGPHIFN | 2.155 | — | P15477 P11768 Q42502 Q3YJT3 | 23 | — | — | 95.1 | 2688.0 | 7.53 | 0.2 |
| α-14 | AKDIVPFYFEHGPHIFN | 2.255 | — | P15477 P11768 Q42502 Q3YJT3 | 17 | — | — | 89.5 | 2031.3 | 6.05 | -0.8 |
| α-15 | IPATILEFLEGQLQEVDNN | 2.000 | — | P15477 P11768 Q42502 Q3YJT3 | 19 | — | — | 86.3 | 2143.4 | 0.61 | −4 |
| α-16 | ILEFLEGQLQEVDN | 2.978 | — | P15478 P15477 P11768 Q42502 Q3YJS9 Q3YJT3 | 14 | — | — | 83.7 | 1646.8 | 0.61 | −4 |
| α-17 | KYDGKYLMQVLQE | 2.029 | — | P15478 Q3YJT5 Q2MY60 Q2MY43 Q3YJS9 | 13 | — | — | 89.8 | 1614.9 | 6.67 | 0 |
| α-18 | KYLMQVLQEKLGE | 2.022 | — | P15478 Q3YJT5 Q2MY60 Q3YJS9 | 13 | — | — | 96.8 | 1578.9 | 6.77 | 0 |
| α-19 | KYLMQVLQEKL | 2.058 | — | P15478 Q3YJT5 Q2MY60 Q3YJS9 | 11 | — | — | 74.5 | 1392.7 | 9.49 | 1 |
| β-20 | ELDSRLSYRIISTFWGALGGDVYLGKSPN | 2.630 | — | Q3S474 A0A097H149 Q66LL8 Q66LL2 | 29 | — | — | 75.0 | 3215.6 | 6.87 | 0 |
| β-21 | ELDSRLSYRIISTFWGALGGDVYL | 3.131 | — | Q3S474 A0A097H149 Q66LL8 Q66LL2 | 24 | — | — | 70.0 | 2732.0 | 4.17 | −1 |
| β-22 | CPFSSDDQFCLKVGV | 2.501 | — | Q3S474 A0A097H149 L0AQL9 Q2XPX8 Q2XPY0 | 15 | 13 | 33 | 78.9 | 1644.9 | 3.71 | −1.1 |
| β-23 | FIPLSTNIFEDQLLNIQFNIPT | 2.391 | — | Q3S488 Q3S482 Q3S479 H9B8I8 | 22 | — | — | 89.9 | 2577.9 | 0.69 | −2 |
| β-24 | LNIQFNI | 4.066 | — | Q8RXA3 Q3S489 Q3S488 Q3S481 Q38M77 Q3S482 Q3S479 H9B8J1 H9B8I9 H9B8I8 H9B8J0 | 7 | — | — | 95.3 | 861 | 3.66 | 0 |
| β-26 | GKELDPRLSYRI | 2.218 | — | Q3S477 Q2XPX8 Q2XPY0 Q8LJQ0 | 12 | — | — | 86.9 | 1446.7 | 9.73 | 1 |
| β-27 | LNIQFNIPTPKLC | 2.213 | — | Q3S488 Q8RXA3 Q3S482 Q3S479 H9B8J1 | 13 | 23 | 31 | 70.6 | 1500.8 | 8.84 | 0.9 |
| β-28 | VHQNGKRRLALVKDNPLDVSFK | 2.056 | — | Q3S474 A0A097H149 Q2XPX8 Q2XPY0 | 22 | — | — | 94.2 | 2534.9 | 10.92 | 3.1 |
| β-29 | IGSSSHFGPHIFEGELLNIQFDIS | 2.027 | — | Q3S477 Q2XPX8 Q2XPY0 Q8LJQ0 | 24 | — | — | 84.7 | 2644.9 | 4.3 | −2.8 |
| β-30 | DDNFCAKVGVVIQ | 2.016 | — | Q3S489 Q3S488 Q3S481 Q38M77 Q3S479 H9B8I9 | 13 | — | — | 80.3 | 1407.6 | 3.71 | −1.1 |
| β-31 | LGGDVYLGKSPNSDAPCP | 2.011 | — | Q8RXA3 Q3S488 Q3S481 Q38M77 Q3S482 Q3S479 H9B8I9 H9B8I8 H9B8J0 | 18 | — | — | 91.8 | 1789.9 | 3.71 | −1.1 |
| γ-1 | GIKGIIPAIILEFLEGQLQEVDNNKDAR | 4.146 | 14 | P15477 P11768 | 28 | 75 | 0 | 99.4 | 3094.5 | 4.2 | −2 |
| γ-34 | CRDDNFCAKVGVVI | 3.387 | 5 | Q3S488 Q3S481 Q38M77 Q3S489 Q3S479 H9B8I9 | 14 | — | — | 89.0 | 1538.8 | 5.9 | −0.1 |
| γ-35 | RDDNFCAKVGVVI | 3.933 | 4 | Q3S488 Q3S481 Q38M77 Q3S489 Q3S479 H9B8I9 | 13 | — | — | 87.8 | 1435.7 | 6.05 | −0.1 |
| γ-36 | FDVIGGTSTGGLLTAMITTPNENNRP | 3.190 | 17 | P15477 Q3YJT5 P11768 Q2MY60 Q42502 Q3YJT3 | 26 | 31 | 23 | 78.6 | 2676.9 | 3.93 | −1 |
| γ-37 | LLTAMITTPNENNRP | 4.037 | 6 | P15477 Q3YJT5 P11768 Q2MY60 Q42502 Q3YJS9 Q3YJT3 | 15 | — | — | 77.6 | 1684.9 | 6.86 | 0 |
| γ−38 | FCLKVGVVHQNGKRRLALVKDNP | 3.168 | 8 | Q3S474 Q2XPX8 A0A097H149 Q2XPY0 | 23 | 0 | 65 | 89.7 | 2592.1 | 10.91 | 4 |
| γ-39 | HQNGKRRLALV | 4.790 | 7 | Q3S474 Q3S477 Q2XPX8 A0A097H149 Q2XPY0 Q66LL8 Q66LL2 Q8LJQ0 | 11 | — | — | 98.3 | 1291.5 | 12.13 | 3.1 |
| γ-40 | SSDDQFCLKVGVV | 3.137 | 5 | Q3S474 Q2XPX8 A0A097H149 Q2XPY0 L0AQL9 | 13 | 0 | 46 | 80.6 | 1396.6 | 3.71 | −1.1 |
| γ-41 | KDNPETYEEALKRFAKLLS | 3.066 | 13 | P15478 Q3YJT5 Q2MY60 Q2MY43 | 19 | — | — | 70.5 | 2252.5 | 6.88 | 0 |
| γ-42 | DTNGKELNPNSSYRIISIGRGALGGDVYL | 3.055 | 14 | Q3S481 Q38M77 Q3S489 H9B8I8 H9B8J0 | 29 | — | — | 79.0 | 3080.4 | 6.89 | 0 |
| γ-43 | NPNSSYRIISI | 3.401 | 7 | Q3S481 Q38M77 Q3S489 H9B8I8 H9B8J0 | 11 | — | — | 98.6 | 1263.4 | 9.41 | 1 |
| γ-44 | DNFCAKVGVVIQNGKRR | 3.044 | 11 | Q3S488 Q3S481 Q3S489 Q3S479 H9B8I9 | 17 | — | — | 72.3 | 1904.2 | 10.68 | 2.9 |
| γ-45 | VGVVIQNGKRR | 4.779 | 5 | Q8RXA3 Q3S488 Q3S481 Q3S489 Q3S482 Q3S479 H9B8J1 H9B8I9 H9B8J0 | 11 | — | — | 94.6 | 1225.5 | 12.13 | 3 |
| γ-46 | FAKLLSDRKKLRANK | 3.043 | 5 | P15478 P15477 P11768 Q2MY60 Q2MY43 Q42502 Q3YJS9 Q3YJT3 | 15 | — | — | 95.2 | 1788.2 | 11.57 | 5 |
| γ-47 | TPNENNRPFAAAKDIV | 3.024 | 8 | P15477 Q3YJT5 P11768 Q42502 Q3YJT3 | 16 | — | — | 97.3 | 1756.9 | 6.62 | 0 |
| γ-48 | GIIPATILEFLEGQLQEVDNN | 3.003 | 11 | P15478 Q42502 Q3YJS9 Q3YJT3 | 21 | — | — | 92.2 | 2313.6 | 0.61 | −4 |
| γ-49 | FCLKVGVIHQNGKRRLALVK | 2.478 | 8 | Q3S477 Q8LJQ0 | 20 | 0 | 75 | 99.0 | 2279.8 | 11.49 | 5 |
*Predicted amphiphilic score.
**AA used by the algorithm to define the divide between the hydrophobic and hydrophilic part of the peptide.
***Fraction of residues located in a given secondary structure conformation (within the native protein) as implied by homology modelling. This was carried out only for the 9 selected peptides.
****Purity of the synthetic peptides used as received from pepMic Co., Ltd (Jiangsu, China).
*****pI and net charge were calculated by using peptide property calculator from INNOVAGEN (Innovagen AB, Lund, Sweden).
Figure 2Interfacial tension at the MCT oil-aqueous phase interface, with the aqueous phase containing 0.2 wt.% peptides in 10 mM sodium acetate - 10 mM imidazole buffer (pH 7): (a) α-peptides, (b) β-peptides, and (c) γ-peptides. The bare MCT oil-water interfacial tension was 26 mN/m.
Values of pH, droplet size, zeta potential and observations on creaming of the emulsions.
| Emulsion | Solubility | pH | D4,3 (μm)** | Zeta potential | Observations*** | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Day 0 | Day 1 | Day 3 | Day 6 | Day 0 | Day 1 | Day 6 | ||||
| α-10 | Soluble | 6.3 | 1.9 ± 1.3a | 1.5 ± 0.6a | 4.3 ± 0.6a | 5.5 ± 0.4b,* | 28.0 ± 2.1e | 1 | 1 | 1 |
| α-11 | Soluble | 6.5 | 40.4 ± 10.6c | 60.9 ± 8.2b | — | — | −27.6 ± 4.6c | 4 | 4 | 4 |
| α-12 | Soluble | 6.3 | 0.3 ± 0.02a | 2.3 ± 0.8a | 2.7 ± 1.0a | 3.0 ± 0.5a,b,* | −54.8 ± 3.5b | 1 | 1 | 1 |
| α-13 | Soluble | 6.5 | 94.9 ± 6.1d | 111.6 ± 33.1c | — | — | −26.3 ± 0.7c,d | 4 | 4 | 4 |
| α-14 | Soluble | 6.1 | 16.3 ± 1.2b | 11.8 ± 1.9a | 11.8 ± 0.1b | 12.8 ± 3.3c,ns | −15.5 ± 3.8d | 2 | 2 | 3 |
| α-15 | Soluble | 5.6 | 0.3 ± 0.07a | 0.3 ± 0.06a | 0.3 ± 0.07a | 0.3 ± 0.07a,ns | −69.1 ± 3.9a | 1 | 3 | 3 |
| α-16 | Soluble | 5.7 | 1.0 ± 0.9a | 0.3 ± 0.09a | 0.4 ± 0.0a | 0.4 ± 0.0a,ns | −67.0 ± 3.5a | 3 | 3 | 3 |
| α-17 | Cloudy | 6.5 | 9.3 ± 3.0a,b | 17.4 ± 3.7a | 34.6 ± 0.7d | 24.2 ± 0.1e,* | −31.2 ± 2.7c | 2 | 2 | 2 |
| α-18 | Cloudy | 6.1 | 8.9 ± 0.3a,b | 12.8 ± 1.7a | 15.8 ± 1.8b | 26.0 ± 2.9e,* | −46.8 ± 6.9b | 2 | 2 | 2 |
| α-19 | Soluble | 6.7 | 21.3 ± 5.5b | 31.9 ± 4.7a,b | 22.4 ± 4.0c | 18.2 ± 1.6d,ns | −24.0 ± 4.0c,d | 1 | 2 | 2 |
| β-20 | Cloudy | 6.2 | 14.0 ± 1.5a,b | 14.8 ± 1.2a,b | 26.9 ± 4.1b | 37.6 ± 1.7c,* | −30.5 ± 4.2c,d | 2 | 2 | 2 |
| β-21 | Cloudy | 6.9 | 24.1 ± 9.7b | 28.1 ± 4.6a,b,c | 38.6 ± 2.8c,d | 42.8 ± 2.1d,* | −37.6 ± 3.1c | 2 | 2 | 2 |
| β-22 | Soluble | 6.1 | 6.0 ± 0.6a | 6.1 ± 0.5a,b | 6.1 ± 0.9a | 8.5 ± 0.1a,b,* | −70.9 ± 3.0a | 1 | 1 | 1 |
| β-23 | Cloudy | 6.6 | 16.9 ± 1.7a,b | 26.5 ± 6.4a,b,c | 29.9 ± 6.2b,c | 33.6 ± 0.2c,* | −54.0 ± ± 0.9b | 1 | 1 | 1 |
| β-24 | Cloudy | 6.4 | 40.6 ± 1.4c | 41.9 ± 11.6c | — | — | −36.2 ± 13.3c | 4 | 4 | 4 |
| β-26 | Soluble | 6.3 | 50.1 ± 14.7c | 98.0 ± 26.5d | — | — | −19.2 ± 4.9d | 4 | 4 | 4 |
| β-27 | Cloudy | 6.3 | 2.6 ± 0.9a | 2.4 ± 0.1a | 4.3 ± 0.5a | 5.4 ± 1.1a,* | 15.8 ± 2.9e | 1 | 1 | 1 |
| β-28 | Soluble | 6.1 | 6.9 ± 2.3a | 31.1 ± 0.06b,c | 40.3 ± 4.8d | — | −29.9 ± 2.9c,d | 2 | 4 | 4 |
| β-29 | Cloudy | 6.3 | 12.0 ± 0.2a,b | 15.0 ± 0.9a,b | 12.9 ± 0.4a | 10.6 ± 0.9b,ns | −28.9 ± 1.1c,d | 2 | 2 | 2 |
| β-30 | Cloudy | 6.0 | 10.5 ± 0.1a,b | 12.4 ± 2.1a,b | 10.5 ± 0.3a | 10.7 ± 0.1b,ns | −21.8 ± 2.1d | 2 | 2 | 2 |
| β-31 | Soluble | 6.1 | 2.9 ± 0.6a | 6.1 ± 0.6a,b | 8.7 ± 0.6a | 12.4 ± 3.5b,* | −21.8 ± 0.9d | 3 | 3 | 3 |
| γ-1 | Soluble | 6.2 | 0.6 ± 0.2a | 0.7 ± 0.2a | 0.6 ± 0.2a | 0.6 ± 0.2a,ns | −61.3 ± 3.1b | 1 | 1 | 1 |
| γ-34 | Cloudy | 6.0 | 16.6 ± 1.3a | 18.4 ± 0.7d | 20.7 ± 0.7d | 21.1 ± 0.9e,* | −20.2 ± 7.5e | 2 | 2 | 2 |
| γ-35 | Cloudy | 6.0 | 24.0 ± 0.0a,b | 25.6 ± 1.4e | 34.2 ± 1.0d | 31.7 ± 1.4f,* | −24.5 ± 3.4d,e | 2 | 2 | 2 |
| γ-36 | Soluble | 6.4 | 0.8 ± 0.0a | 3.8 ± 0.8b | 3.3 ± 0.1a,b | 2.5 ± 0.2a,b,* | −54.5 ± 1.7b | 1 | 1 | 1 |
| γ-37 | Soluble | 6.1 | 0.6 ± 0.0a | 0.5 ± 0.0a | 0.8 ± 0.5a | 0.7 ± 0.4a | −39.2 ± 1.7c | 3 | 3 | 3 |
| γ-38 | Soluble | 6.1 | 5.7 ± 0.1a | 4.1 ± 0.9b | 5.7 ± 1.7b | 8.8 ± 0.1c,d | 34.6 ± 3.2g | 1 | 1 | 1 |
| γ-39 | Soluble | 6.8 | 54.9 ± 0.0b,c | — | — | — | −21.5 ± 1.4e | 4 | 4 | 4 |
| γ-40 | Cloudy | 6.8 | 1.0 ± 0.1a | 1.0 ± 0.1a | 0.9 ± 0.1a | 0.9 ± 0.1a,ns | −55.6 ± 2.2b | 1 | 1 | 1 |
| γ-41 | Soluble | 6.5 | 69.8 ± 17.1c | — | — | — | −29.4 ± 7.2c,d,e | 4 | 4 | 4 |
| γ-42 | Cloudy | 6.9 | 1.3 ± 0.3a | 3.5 ± 1.8b | 2.1 ± 0.1a,b | 7.2 ± 1.5c,* | −35.4 ± 1.7c,d | 1 | 2 | 2 |
| γ-43 | Soluble | 7.0 | 60.3 ± 41.2c | — | — | — | −24.9 ± 5.4dd,e | 4 | 4 | 4 |
| γ-44 | Cloudy | 7.0 | 2.4 ± 0.2a | 6.8 ± 0.7c | 10.4 ± 4.3c | 11.0 ± 0.0d,* | 30.0 ± 1.05f,g | 1 | 1 | 1 |
| γ-45 | Soluble | 6.8 | 82.5 ± 10.5c | — | — | — | −22.7 ± 2.3e | 4 | 4 | 4 |
| γ-46 | Soluble | 6.4 | 87.5 ± 4.5c | — | — | — | −20.4 ± 4.4e | 4 | 4 | 4 |
| γ-47 | Soluble | 6.1 | 123.7 ± 8.8d | — | — | — | −21.5 ± 4.3e | 4 | 4 | 4 |
| γ-48 | Soluble | 5.9 | 0.4 ± 0.0a | 0.7 ± 0.4a | 2.4 ± 1.4a,b | 2.4 ± 1.7a,b,ns | −78.2 ± 2.9a | 1 | 3 | 3 |
| γ-49 | Soluble | 6.7 | 1.7 ± 0.3a | 0.8 ± 0.0a | 1.3 ± 0.2a,b | 4.5 ± 0.3b,* | 18.9 ± 3.8f | 1 | 1 | 2 |
| Casein | Soluble | 6.9 | 1.1 ± 0.2 | 1.1 ± 0.2 | 0.9 ± 0.2 | 1.0 ± 0.2 | −41.5 ± 1.1 | 1 | 1 | 1 |
*Solubility of peptides in 10 mM sodium acetate - 10 mM imidazole buffer (pH 7). Soluble: totally soluble; cloudy: no totally soluble.
**No values (—) were obtained for emulsions with phase separation.
***The number codes stand for: 1: no creaming; 2: creaming; 3: oil layer above the emulsion; 4: phase separation.
For each type of peptides, different letters in the same column indicate significant differences between samples (p<0.05). ‘ns’ indicates not significant differences (p>0.05), whereas ‘*’ indicates significant differences (p<0.05) in D4,3 between days 1 and 6 for the same emulsion.
Figure 3Left: Localization of predicted emulsifier peptides based on template homology modelling using SWISS-MODEL Workspace[39] (https://swissmodel.expasy.org/) and visualized in PyMOL version 1.5.0 (https://pymol.org/2/). Models are made using the protein of origin for the predicted peptides (Table 1). (a) Patatin-B2 (UniProt AC# P15477) was modelled using the X-ray structure of Patatin-17 (SMTL ID 4pka.1.A) as template, showing localization of the overlapping α-10 and α-12 (red), γ-1 (blue), and γ-36 (green). (b) KTI-A (UniProt AC# Q3S488) was modelled using the X-ray structure of Aspartic Protease inhibitor 11 (SMTL ID 5dzu.1.A) as template, showing localization of β-27 (red). (c) KTI-B (UniProt AC# Q3S474) was modelled using the X-ray structure of Kunitz-type protease inhibitor P1H5 (SMTL ID 3tc2.1.A) as template, showing localization of the overlapping β-22, γ-38, and γ-40 (red). The model for γ-49 (UniProt AC# Q3S477) using P1H5 (SMTL ID 3tc2.1.A) is superimposable with the model for the remaining KTI-B-derived peptides (i.e. γ-49 has the same structure) and is shown on the same model for simplicity. Right: Secondary structure of predicted peptides (as found within the models for their proteins of origin) with visible side chains and residue coloring according to the Swiss-Model hydrophobicity color scale (most hydrophobic residues in red and most hydrophilic residues in blue). Individually visualized proteins/peptides were assembled into the final figure using INKSCAPE version 0.92.3 (https://inkscape.org/).
Figure 4PBN-lipid derived spin adducts generation resulting from the oxidation of 5 wt.% fish oil-in-water emulsions stabilized with selected synthetic potato peptides during storage in the dark at: (a) 20 °C, and (b) 37 °C. For the last sampling point, different letters indicate significant differences between samples (p < 0.05).
Figure 5In vitro antioxidant capacity of selected synthetic potato peptides (0.2 wt.% at pH 7): (a) DPPH radical scavenging activity, and (b) reducing power. Different letters indicate significant differences between samples (p<0.05).
Figure 6SDS-PAGE (4–20% gradient gel) analysis of the potato side stream samples analyzed in this work. 1: MW marker (Pierce Unstained Protein MW Marker P/N 26610). 2: AKV-Feed. 3: AKV-K2. 4: KMC-Feed. 5: KMC-Food. 6: AKV-PFJ. 7: MW marker.
Figure 7Overview of protein structural/functional classes (i.e. proteins with a high degree of sequence conservation) within the potato proteome with emphasis on the most abundant classes based on riBAQ abundance determined in this work. End groups (illustrated in squares) are regarded as sufficiently related to be regarded as isoforms of the same proteins with a high probability of localizing identical embedded peptides. The figure was created using INKSCAPE version 0.92.3 (https://inkscape.org/).
Relative molar distribution of quantified potato proteins by MaxQuant riBAQ analysis of LC-MS/MS data and apparent weight distribution based on 1D SDS-PAGE lane intensity profile analysis according to classes outlined in Fig. 7.
| Protein Class | Molecular weight | PFJ* (ref) | AKV-Feed | AKV-K2 | KMC-Feed | KMC-Food | AKV-PFJ | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MS | SDS** | MS | SDS** | MS | SDS** | MS | SDS** | MS | SDS** | |||
| Lipoxygenase | 90–100 kDa | ~10% | 0.8% | — | 0.2% | — | 0.8% | — | 1.4% | 3.9% | 3.2% | 6.0% |
| Patatin | 40–50 kDa | 25–40% | 56% | 25% | 27% | — | 60% | 28% | 29% | 35% | 28% | 29% |
| Inhibitors | — | ~40% | 31% | 68% | 33% | 100% | 23% | 72% | 53% | 58% | 44% | 62% |
| − KTIs | 20–24 kDa | ~30% | 30% | 48% | 15% | 12% | 22% | 43% | 51% | 42% | 41% | 37% |
| − PINs | 12–16 kDa | ~5% | 1.2% | 12% | 13% | 33% | 0.5% | 14% | 1.7% | 15% | 2.8% | 16% |
| − MCPIs | ~10 kDa | ~4% | 0.2% | 8.4% | 4.8% | 55% | 0% | 15% | 0% | 1.7% | 0.1% | 8.0% |
| Histones | N/A | ~1% | 0.8% | N/A | 3% | N/A | 1.2% | N/A | 0.1% | N/A | 0.7% | N/A |
| Uncharacterized | N/A | N/A | 4.7% | N/A | 18% | N/A | 6.3% | N/A | 8% | N/A | 11% | N/A |
| Other | N/A | N/A | 7% | N/A | 19% | N/A | 9% | N/A | 9% | N/A | 13% | N/A |
All Kunitz-type inhibitors and proteinase inhibitors have been grouped for simplicity. *PFJ protein distribution (by weight) as determined by UV/Vis spectrophotometry and BCA assays based on Bauw et al. (2006).
**SDS-PAGE-based distribution is based only on MW-range distribution and may include other proteins of comparable MW.
Sequence identity between quantified protein isoforms (patatins, Kunitz type-A, and Kunitz type-B) and the selected nine peptides from bioinformatic prediction and in vitro functional validation.
| Sample | Peptide | Patatin | KTI-A | KTI-B | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Identity | γ-1 | γ-36 | α-10 | α-12 | β-27 | β-22 | γ-38 | γ-40 | γ-49 | |
| AKV-Feed | 100% | 20.2% | 50.3% | 26.2% | 26.2% | 8.8% | 5.1% | 5.1% | 5.1% | 0.0% |
| >90% | 50.5% | 54.5% | 50.5% | 50.5% | 11.3% | 5.1% | 5.1% | 7.6% | 5.1% | |
| AKV-K2 | 100% | 9.5% | 24.5% | 14.5% | 14.5% | 4.1% | 5.5% | 5.5% | 5.5% | 0.0% |
| >90% | 25.2% | 25.9% | 24.5% | 24.5% | 5.8% | 5.5% | 5.5% | 7.0% | 5.5% | |
| KMC-Feed | 100% | 43.6% | 53.8% | 37.1% | 37.1% | 8.3% | 3.4% | 3.4% | 3.4% | 0.0% |
| >90% | 54.5% | 59.0% | 54.1% | 54.1% | 10.2% | 3.4% | 3.4% | 3.4% | 3.4% | |
| KMC-Food | 100% | 11.1% | 26.0% | 13.8% | 13.8% | 12.3% | 6.9% | 6.8% | 6.9% | 0.1% |
| >90% | 17.0% | 28.9% | 26.1% | 26.1% | 15.9% | 6.9% | 7.0% | 10.2% | 7.0% | |
| AKV-PFJ | 100% | 16.9% | 21.7% | 16.3% | 16.3% | 8.9% | 6.2% | 6.2% | 6.2% | 0.2% |
| >90% | 24.3% | 26.8% | 22.0% | 22.0% | 12.9% | 6.2% | 6.5% | 8.4% | 6.5% | |
Relative abundance (in % riBAQ within each sample) is given for all proteins with 100% identity and >90% identity with the respective predicted peptide. Sequence identity evaluation was performed using CLC SEQUENCE VIEWER version 8.0 (https://www.qiagenbioinformatics.com/).
Sequences of the nine selected emulsifier peptides including a 15 AA N- and C-terminal cleavage window.
| Peptide | Protein | Sequence (w. cleavage windows) |
|---|---|---|
| γ-1 | P15477 | A |
| γ-36 | P15477 | LQEVDNN |
| α-10 | P15477 | EANMELLVQVGETLL |
| α-12 | P15477 | LVQVGETLL |
| β-27 | Q3S488 | V |
| β-22 | Q3S474 | QLGYNLLYCPVTSTMI |
| γ-38 | Q3S474 | PVTSTMICPFSSDDQ |
| γ-40 | Q3S474 | NLLYCPVTSTMICPF |
| γ-49 | Q3S477 | YCPATMICPFCSDDE |
The sequence of the predicted peptide is highlighted in italics and tryptic residues are highlighted in bold. Several peptides are located close (<15 AAs) to the protein C-terminus and * indicates the terminal residue.